About this episode

The episode discusses Dihexa, a synthetic peptide that may rewire the brain but lacks human clinical trial data.

Dihexa is a synthetic peptide developed at Washington State University that has gained significant attention in the biohacking community for its potential to physically rewire the brain . Unlike traditional nootropics that focus on neurotransmitter levels, this compound appears to encourage synaptogenesis , or the creation of new neural connections, by enhancing HGF/c-Met signaling . While animal studies and laboratory models have shown remarkable results in treating cognitive decline and brain injury , there is a complete lack of human clinical trial data regarding its safety or effectiveness. This absence of formal research leaves critical questions unanswered about optimal dosing and long-term risks, including a theoretical concern regarding tumor promotion . Consequently, the substance remains a controversial topic, defined by a sharp divide between mythologized online anecdotes and a lack of verified medical evidence.

Topics covered

• synthetic peptides
• biohacking
• cognitive enhancement
• neural connections
• brain injury
• clinical trials

Mentioned in this episode

Organizations: Washington State University

Products: Dihexa, HGF/c-Met

More episodes of Today's discussion on unraveling BPC 157 Peptide

• ARA-290: The Science of Regenerative Nerve Repair · July 15, 2026 · 22 min
• GHK-Cu: The Science of the Copper Peptide · June 22, 2026 · 20 min
• NAD+ and Epitalon: The Longevity Stack · June 15, 2026 · 22 min

Explore listener stats, chart rankings, contacts and more on the Today's discussion on unraveling BPC 157 Peptide podcast page.